Loading clinical trials...
Loading clinical trials...
Phase I/II Clinical Trial of Haematopoietic Stem Cell Gene Therapy for the Wiskott-Aldrich Syndrome
Conditions
Interventions
Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene
Locations
1
France
Hôpital Necker-Enfants Malades
Paris, France
Start Date
May 1, 2011
Primary Completion Date
January 13, 2016
Completion Date
January 9, 2017
Last Updated
May 22, 2018
NCT01852370
NCT03837483
NCT00909363
NCT03399461
NCT01289847
NCT00885833
Lead Sponsor
Genethon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions